Please try another search
For the six months ended 30 June 2019, Corindus Vascular Robotics Inc revenues increased from $3.2M to $7.6M. Net loss applicable to common stockholders decreased 14% to $22.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Restructuring charge decrease from $349K (expense) to $0K, Interest Income increase from $66K to $192K (income).
Period Ending: | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
---|---|---|---|---|
Total Revenue | 4.58 | 3.04 | 4.67 | 2.96 |
Gross Profit | 1.8 | 0.62 | 1.91 | 1.12 |
Operating Income | -10.29 | -9.4 | -7.29 | -7.28 |
Net Income | -10.66 | -9.68 | -7.43 | -7.59 |
Period Ending: | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
---|---|---|---|---|
Total Assets | 42.69 | 47.66 | 33.52 | 37.88 |
Total Liabilities | 24.85 | 22.55 | 19.78 | 18.3 |
Total Equity | 17.84 | 25.11 | 13.75 | 19.58 |
Period Ending: | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 0 Months |
Cash From Operating Activities | -16.11 | -8.58 | -32.03 | -26.17 |
Cash From Investing Activities | -0.25 | -0.09 | -0.74 | -0.41 |
Cash From Financing Activities | 24.45 | 22.57 | 39.16 | 38.76 |
Net Change in Cash | 8.09 | 13.91 | 6.39 | 12.18 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review